ENCORE: A New Revolutionary Technology That Can Predict Cardiovascular Risk With Precision, Part 2
May 7, 2024
29:51
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Hoffman continues his conversation with Dr. James Min, an expert on cardiovascular imaging and founder and CEO of Cleerly, a company that has developed an improved scan that can differentiate between dangerous unstable plaque, and more benign lesions.